Advertisement

Medtronic reveals a year-old Dept. of Justice probe into the medical device company's insulin pump replacement practices.

Medtronic logo

Medtronic (NYSE:MDT) may have found itself in another bind with the U.S. Justice Dept., according to the medical device giant's latest financial report.

In August 2011 the company received a DoJ request for more information about insulin pump replacements for Medicare beneficiaries, Medtronic reported. The device maker is "fully cooperating with this inquiry."

Medtronic did not respond to requests for comment.

Advertisement
Advertisement